Trials / Completed
CompletedNCT00980707
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarker of Asthma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Associated Scientists to Help Minimize Allergies · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.
Detailed description
We will compare spirometry, eNO and sputum measurements of versican and hyaluronan before and after treatment with fluticasone 220 ug/bid.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled corticosteroid (fluticasone) | inhaled fluticasone 220 ug/bid |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-06-01
- Completion
- 2010-11-01
- First posted
- 2009-09-21
- Last updated
- 2012-01-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00980707. Inclusion in this directory is not an endorsement.